"I believe that morally everyone must take the vaccine," Pope Francis I heard from a friend that a relation of hers - a man in his fifties with no health issues and fit as a fiddle took the Astra Zeneca vaccine and immediately became unwell. He died a few days later of a brain clot in hospital. There is absolutely no doubt that the vaccine killed him. My friend's family and wider circle have now been put off taking the vaccine - they are scared. The chances of this man dying from covid was extremely remote. Very unlikely. But he is dead now because of the vaccine. Let us say that this man took the vaccine (he was a Catholic) because he believed Pope Francis that it was 'the morally right thing to do'. How accountable will God hold Pope Francis for the death of those who take the vaccines because he endorsed it most strongly as the 'morally right thing to do'?
I agree, our parish priest has posted that "we are NOT to be selfish as we ARE morally obligated to take the vaccine."
Imagine the scenario -- My unbelieving son using Pope Francis as an argument to undermine my pro-life stance over these vaccines. If Pope Francis had been near me today he would have got an earful from me.
I wonder how he would feel if you replaced the vaccine with the chip? The slippery slope argument. I don't let others 'control' me, a sister of mine tried that. She won't speak to me now, it's her loss. But to thine own self be true . . .
I personally know people who have had Covid, most with mild cold symptoms, including my son in seminary studying to be a Norbertine priest. On the other hand I know someone who died immediately following their second vaccine dose, presumably also due to brain clot. Yes, this is simply anecdotal. But I don’t like what I’m seeing. Brain clots are emerging as one of the primary causes of death among those getting this vaccine, and there are now several thousand deaths related to the vaccine worldwide. Furthermore... Do some research on “Antibody-Dependent Enhancement (ADE) and coronavirus.” You’ll find some people saying there’s nothing to worry about. And some trying (but largely being ignored) to raise an alarm. If ADE does become a serious issue among those already vaccinated, the more cynical suspect the powers that be will just blame it on Covid “variants” and they’ll push subsequent vaccine boosters even more. And some of the most cynical say this secondary long term ADE has been the plan all along, to reduce the global population.
Brian - you would probably find this breakdown of vaccine related injuries to be of interest reported trough the VAERS system -- of course vastly under-rated as it is voluntary system -- VAERS data released today showed 50,861 reports of adverse events following COVID vaccines, including 2,249 deaths and 7,726 serious injuries between Dec. 14, 2020 and March 26, 2021. https://childrenshealthdefense.org/...tent&eId=9af36675-e8d3-4040-a6be-abcb46990996
Oh Katfalls, I will be praying for your cousin in my rosary tonight. Do you know which shot{I won't call it a vaccine} they got?
These clots are NOT “rare.” They’re being reported worldwide. https://www.ibtimes.com/scientists-discover-cause-blood-clots-astrazeneca-covid-19-vaccine-3166638 Scientists Discover Cause Of Blood Clots From AstraZeneca COVID-19 Vaccine Danielle Ong03/22/21 AT 12:12 AM Two teams of scientists in Europe on Friday said they have discovered the cause of rare blood clots among some patients who received a AstraZeneca COVID-19 vaccine dose. A group of German scientists led by Professor Andreas Greinacher at the University of Greifswald in a statementsaid they believe the AstraZeneca shot prompts an overactivation of platelets in the blood. This leads to the development of potentially deadly clots. Greinarcher’s team analyzed 13 cases of cerebral blood clots reported in Germany. The analysis involved 12 women and 1 man who developed blood clots between four and 16 days after inoculation. The researchers were able to isolate and identify the antibodies that caused the overactivation of the platelets. A team at Oslo University Hospital in Norway investigated three cases of post-vaccination blood clots. All three cases involved health care workers under the age of 50 in Norway. One worker has since died. Professor Pal Andre Holme told the Norwegian newspaper VG that his team has confidently identified the antibodies responsible for the clots. "Our theory that this is a strong immune response that most likely comes after the vaccine," he said, echoing the findings made by the German team. "There is no other thing than the vaccine that can explain this immune response." The researchers said the blood clots can easily be treated and warned AstraZeneca vaccine recipients to seek medical care if they experience unusual bruising, swelling or headaches four or more days after receiving the COVID-19 vaccine shot. Earlier this month, roughly 30 people developed cerebral venous sinus thrombosis or CVST after receiving a shot of the AstraZeneca vaccine, with some cases becoming fatal. CVST is a rare form of stroke that happens when a blood clot forms in the brain’s venous sinuses, preventing blood from draining out of the brain. Blood cells could then break and blood could leak into brain tissue, leading to a hemorrhage. It affects five people per million every year. Most of the people who developed the rare condition were women under the age of 55. This prompted more than a dozen counties in the European Union to suspend administering the AstraZeneca vaccine. Most countries, including Germany, France and Italy, resumed vaccinations with AstraZeneca’s shot Friday after the European Medicines Agency declared that it was safe and effective. European nations have got back to administering AstraZeneca jabs after a blood clot scare, but its reputation has suffered Photo: ANP / Piroschka van de Wouw
https://www.kctv5.com/content/tncms/live/ Here's what to know about the risk of blood clots and the AstraZeneca vaccine (CNN) -- The UK's medicines regulator has said that at least 30 people in the United Kingdom had experienced rare types of blood clots after receiving the Oxford-AstraZeneca vaccine, but warned it was too early to know whether the shot itself triggered the clots. The Medicines and Healthcare products Regulatory Agency (MHRA) said in a statement it received 22 reports of cerebral venous sinus thrombosis (CVST), where clotting forms in the sinuses that drain blood from the brain, and eight other reports of thrombosis, out of a total of 15.8 million people who had been given at least one dose of the vaccine by March 21. A breakdown of the MHRA's CVST data showed four people had died, but the agency did not immediately respond to CNN's questions to confirm whether there had been fatalities. The agency has advised the UK continue administering the vaccine in all groups, arguing that such clotting incidents are very rare and that the benefits still greatly outweighed the risks, echoing similar assessments by the European Medicines Agency(EMA) and the World Health Organization (WHO). But more and more reports of blood clots from different countries are dripping in, particularly in Europe, where the AstraZeneca vaccine is widely used. Some countries are choosing to suspend the vaccine altogether, while others have limited its use to certain age groups. Germany on Tuesday said it would limit the vaccine to people over the age of 60, after 31 reports of CVST. Twenty-nine of the 31 were women aged 20 to 63, and nine of the patients died, according to a Reuters report citing the country's medicines regulator. So far, at least 2.7 million Germanshave been vaccinated with a first dose of AstraZeneca. Complications have been reported in one out of 100,000 AstraZeneca vaccinations, according to the country's health ministry. It did not detail what those complications were and how serious they were. As of March 30, three deaths in people who experienced a combination of blood clotting, low platelet count and hemorrhaging three to 14 days after receiving the vaccine were reported in Norway, the country's medicines agency said in a report. Norway has administered at least one does of the AstraZeneca to more than 134,00 people. "The Norwegian Medicines Agency believes that there is a probable link with the vaccine, but we need more research to clarify exactly what is triggering this," it wrote. Denmark reported two cases of blood clots and low blood platelet counts after the vaccine; one of the cases was fatal. Here's what else to know. How can scientists determine whether there's a link? One indicator to look at is the rate of incidence. Blood clots in general are so common that it is expected that a certain number of people will get them for various reasons at any given day of any given week. If someone has had a vaccine and then develops a blood clot, it doesn't necessarily mean the shot caused the clot. After initial reports of clotting last month, AstraZeneca was quick to point out that the incidence of clots overall is lower in people who have received the shot that in the general population, in the countries that is using the shot. An AstraZeneca spokesperson said in a statement to CNN on Friday: "Patient safety remains the Company's highest priority," and pointed to authorities in the UK, EU and the WHO's recommendations to continue its use. "The benefit risk profile of the vaccine was reaffirmed in the EMA's monthly safety update," the spokesperson said. To get a clearer picture, scientists are looking more specifically at the types of clots being reported. CVST is rare to begin with, and normally, working out whether the incidence of a blood clot event has risen isn't difficult. In this case, however, it's a little murky, partly because the rate of CVST in the population isn't clear in the first place. The MHRA said that 15.8 million people had received at least one shot of the AstraZeneca vaccine in the UK. With 30 cases of CVST or other thrombosis in the UK, the incidence of developing one of these rare clots is 1.89 in a million. "So the absolute risk of CVST after this vaccine remains extremely low ... and it's not clear if this is any higher than the usual expected incidence of CVST," David Werring from UCL Institute of Neurology told the Science Media Centre. He said the usual incidence of CVST in the UK was probably around 5 to 15 in every million each year, but he added that those figures vary because of the difficulty in diagnosing some cases. What has become a more useful focus for scientists is the nature of these blood clots. Emerging evidence suggests that some cases of blood clots after vaccination have unusual features. While these patients are experiencing blood clots, they are, unusually, also presenting symptoms of thrombocytopenia -- a low count in the very blood platelets that usually prevent clotting, EMA and several other health experts in the region have noted. "This raises the possibility that the vaccine could be a causal factor in these rare and unusual cases of CVST, though we don't know this yet, so more research is urgently needed," Werring said. Experts keep saying the benefits outweigh the risk, but by how much? If you look at this at a global, or even a national, level, the answer is: a lot. Consider this. Since the UK started vaccinating people on December 7 up until March 21, there have been 30 cases of rare blood clots, four of which were fatal. In that same time period, more than 2.5 million people caught Covid-19, and 63,082 people in the country died from the virus, government data show. "It is vital that the vaccination rollout is not delayed," said David Spiegelhalter, chair of the Winton Centre for Risk and Evidence Communication at the University of Cambridge. He pointed to a model that showed that even with current low levels of the virus, delaying vaccinating 500,000 people between the ages of 44 to 54 would likely lead to around 85 hospitalization and likely five deaths. But these dynamics may look different when data by gender and age are taken into account. Spiegelhalter said "it is important to know whether this risk is substantially higher in younger age groups, as has been found elsewhere. Vaccinating younger people is as much for the wider community as for their direct benefit, and so it is reasonable to try to avoid them causing harm, even if extremely rarely." Covid-19 has, on a whole, had more serious health consequences for older age groups. But hospitalization numbers in several parts of Brazil and the US suggest that younger people are becoming more susceptible to severe illness then before. It's not known whether new variants are the reason, vaccination levels, behavior, or a combination of many factors. Are these blood clots likely to be fatal? The numbers coming in are so small, it's difficult to draw conclusions about fatality rates. In Germany, nine of the 31 cases of CVST were fatal. In the UK, four were. A group of blood clotting experts who are looking into possible links between the vaccine and nine cases in Germany have said that the presence of clotting with low blood platelet counts in these people resemble a known blood disorder called heparin-induced thrombocytopenia (HIT), which is "treatable if identified promptly," the experts said in a draft study, which has not yet been peer reviewed. It's a condition that occurs as an adverse reaction to heparin, a blood thinning medicine that is often used to treat CVST. Andreas Greinacher from the University of Greifswald presented some of the group's findings to journalists this week, calling what he thinks is a reaction to the shot "vaccine induced prothrombotic immune thrombocytopenia," or VIPIT. The group is calling on medical professionals to refrain from using heparin in patients presenting with blood clots if they have received the AstraZeneca shot, as the drug could worsen their condition. Sent from my iPhone
https://www.nzherald.co.nz/world/covid-19-coronavirus-australian-man-hospitalised-after-astrazeneca-jab-health-authorities-investigating/ Covid 19 coronavirus: Australian man hospitalised after AstraZeneca jab, health authorities investigating 2 Apr, 2021 05:28 PM An Australian man has been admitted to hospital with a rare blood clotting disorder a few days after receiving the AstraZeneca Covid-19 vaccine. Acting Chief Medical Officer Professor Michael Kidd confirmed the Therapeutic Goods Administration was urgently investigating the reported case after the man presented to Melbourne's Box Hill Hospital on Good Friday with fever and abdominal pain. The man received his vaccine dose on March 22. He was found to have abdominal clots with a very low platelet count when he arrived at hospital. Kidd said it was not yet clear whether the condition was related to the vaccination, following reports of similar instances emerging in European countries and Canada. He said health authorities were taking Australia's case "very seriously". "Cerebral venous thrombosis is a very rare disorder that has previously not been known to be associated with vaccination, however it has been noted as a complication of people who have contracted Covid-19," Kidd said. "No cases of central venous sinus thrombosis have been reported in Australia to date, in the time period of concern following vaccination, which is within four to 20 days. "The TGA has received only one report of a case of thrombosis and thrombocytopenia following vaccination with the AstraZeneca vaccine in Australia but the causal link has not yet been established." Vials of AstraZeneca's Covishield vaccine for Covid-19 are seen at a filling lab at the Serum Institute of India, Pune. Photo / AP Despite this, a new warning has been issued for vaccine patients from the Australian Technical Advisory Group on Immunisation (ATAGI), advising them of the risk. World 1 Apr, 2021 01:00 AMQuick Read World 2 Apr, 2021 01:54 PMQuick Read Kidd advised healthcare workers to be aware of the condition. "This condition has presented as either a clot appearing in the brain or as thrombosis in other sites, including in the intra-abdominal venous systems," he said. "If cerebral venous sinus thrombosis or another severe thrombotic case is suspected in a patient who has received a COVID-19 vaccine, please refer them to an emergency department for further urgent assessment and haematology consultation." Kidd said people who received either of the Covid-19 vaccines should be aware of the common side effects, which include fever, sore muscles, tiredness and headaches usually 24 hours after the dose. "The reports from overseas of rare clotting disorders have occurred later than this. Between day four and day 20, after vaccination, and have generally caused severe symptoms requiring hospitalisation," he said. "People should be particularly alert to severe persistent headaches occurring four to 20 days after vaccination and which are different to the usual pattern of headaches that people may experience at other times and which do not settle with paracetamol or other over the counter painkillers." Seven hundred and fifty thousand doses of Covid-19 vaccines have been administered across Australia as of midday Thursday. The World Health Organisation and the EU's health watchdog have both deemed the AstraZeneca vaccine safe after fears were raised of the jab having serious side effects. Seven people in the UK have died from unusual blood clots after receiving the AstraZeneca Covid-19 jab. However, it remains unclear whether the condition is a side effect of the vaccine or just a coincidence. Out of the 18 million people vaccinated across the UK up to March 24, 30 had presented with the blood clots. Out of those, data showed 22 cases of cerebral venous sinus thrombosis (CVST), a type of blood clot in the brain. Germany recently announced it was restricting vaccine doses for people under 65 after reports of people with "very rare but very serious cases of thrombosis [blood clots]". In March, the European Medicines Agency (EMA) said the shot was not linked to an increased risk of blood clots. However, the EMA's report noted it may be associated with clots linked to thromocytopenia, a rare but serious condition involving low levels of blood platelets. The Australian Technical Advisory Group said there would be no change to the clinical guidance on the use of the AstraZeneca vaccine as a result of the EMA's findings. In a statement it said: "ATAGI considers the benefits of vaccination in protecting people in Australia from Covid-19 outweigh the rare potential risk of these rare blood clotting events, and supports the continued rollout of the AstraZeneca vaccine in Australia." New Zealand has prepurchase agreements with four Covid vaccine suppliers: Pfizer/BioNTech, Janssen Pharmaceutica, Novavax and AstraZeneca. In early March, the Government announced it had secured an extra 8.5 million doses of Pfizer's Covid vaccine, bringing the total number of doses to 10m - enough for every New Zealander. Sent from my iPhone
Prayers. I heard on Face Book from a friend, his forty year old son took the vaccine and was in the ICU that night with a blood clot on the brain. Critically ill. Nothing on the news about it whatsoever. As I am currently banned from Face Book for warning against the vaccine I do not know how he got on. The brain blood clot thing is, I believe, massively under reported. State policy. The Media, the Church and the Government are all in cahoots. (Mustn't scare people, it's all for their own good ect...) Anyway , prayers.
No doubt about it whatsoever. Think of all the people we know personally who have had brain clots and compare that to the amount of media coverage, and their repeated assertions its a “rare” complication. It’s not but they don’t want to let the cat out of the bag. They have to make their money off these vaccines as soon as possible. This July the Emergency Use provisions for these vaccines end. Therefore the universal immunity from civil liability ends too. Watch what happens after that. I suspect they’ll quietly withdraw the vaccines causing these brain clots and you’ll never hear anything more about it.
I wouldn't mind so much if I thought it was all unintended, a genuine mistake. But is it all a mistake? Is it? Or was it all intended from the very beginning, including the release from a Chinese Military, US funded , Base? How much of this was funded and planned from the very highest levels? I wonder, I really, really do. But in any case there is no doubt as you say, they are covering up the brain clot thingy like crazy.
